TABLE 2.

Number and percentage of chronic comorbidities (as elaborated in the supplementary material) at the time of sleep apnoea diagnosis for all those diagnosed with sleep apnoea in Finland in 2017

	Men (n=16 263)		Women (n=9061)
	Cases (n)	Prevalence (%)	Cases (n)	Prevalence (%)	p-value
Cancer	871	5.36	536	5.92	0.070
Kidney and urinary tract disease	555	3.41	232	2.56	<0.001
Thyroid disease	337	2.07	891	9.83	<0.001
Other metabolic disease	563	3.46	552	6.09	<0.001
Diabetes	3324	20.44	1705	18.82	0.006
Obesity	1053	6.47	1053	11.62	<0.001
Gastro-oesophageal reflux disease	311	1.91	335	3.70	<0.001
Dementia and other cerebral disorders	703	4.32	291	3.21	<0.001
Schizophrenia and delusional disorders	215	1.32	141	1.56	0.133
Mood and neurotic disorders	1606	9.88	1746	19.27	<0.001
Nonorganic sleep disorders	355	2.18	335	3.70	<0.001
Neurological disorders	1221	7.51	1232	13.60	<0.001
Glaucoma	234	1.44	193	2.13	<0.001
Hypertension	4217	25.93	2752	30.37	<0.001
Cardiovascular disease	3757	23.10	2202	24.30	0.059
Atrial fibrillation	1496	9.20	634	7.00	<0.001
Other respiratory disease	1653	10.16	1311	14.47	<0.001
Gastrointestinal disease	2671	16.42	2065	22.79	<0.001
Musculoskeletal disease	5797	35.65	4717	52.06	<0.001
Urogenital disease	1440	8.85	206	2.27	<0.001
Heart failure	624	3.84	319	3.52	<0.001
Cerebrovascular disease	532	3.27	296	3.27	0.211
Organic sleep disorders	197	1.21	175	1.93	0.985
Asthma	967	5.94	1137	12.55	<0.001
COPD	572	3.52	293	3.23	0.744
Dyslipidaemia	1745	10.73	985	10.87	0.242